Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

The dataset includes detailed genetic information from mouse skin cells before and after injury.

The dataset includes detailed genetic information from mouse skin cells before and after injury.

GIANT improves brain imaging by using genetics to better map brain regions.

The visfatin GT genotype may increase the risk of Alopecia Areata.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Forensic DNA phenotyping faces challenges due to inconsistent terminology, limited genetic understanding, and debates over technology and models.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Alopecia areata may be linked to scalp microbiome differences, suggesting potential treatments with prebiotics, probiotics, and postbiotics.

ATR-FTIR spectroscopy could help monitor alopecia areata treatment response non-invasively.

Introducing the rat OTC gene partially corrected OTC deficiency in mice.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Increasing SSAT makes skin more prone to cancer.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

The A-T advancement flap is a safe and effective method for scalp reconstruction after basal cell carcinoma removal.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Genomics can improve patient care by using DNA to create personalized treatment plans.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

A new gene mutation causes insulin resistance in a girl and her mother.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

CuATSM speeds up wound healing and reduces scarring.